Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Plasma Exchange for Secondary Organ Dysfunction in ACLF
NCT06276907Not yet recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Improvement in AARC grade by 1 at 14 days. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06276907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276907.